Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Complement Inactivating Agents
Faropenem medoxomil.
Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction.
Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Faropenem medoxomil.
Faropenem medoxomil. Ann Pharmacother. 2008 Jan; 42(1):80-90.
View in:
PubMed
subject areas
Animals
Anti-Bacterial Agents
Bacterial Infections
beta-Lactam Resistance
beta-Lactams
Humans
Microbial Sensitivity Tests
Randomized Controlled Trials as Topic
Time Factors
authors with profiles
Christopher Crank